US3824841A - Method for sedimentation study - Google Patents

Method for sedimentation study Download PDF

Info

Publication number
US3824841A
US3824841A US00191886A US19188671A US3824841A US 3824841 A US3824841 A US 3824841A US 00191886 A US00191886 A US 00191886A US 19188671 A US19188671 A US 19188671A US 3824841 A US3824841 A US 3824841A
Authority
US
United States
Prior art keywords
column
rotation
force
tube
test
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US00191886A
Other languages
English (en)
Inventor
B Bull
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Coulter Electronics Inc
Original Assignee
Coulter Electronics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Coulter Electronics Inc filed Critical Coulter Electronics Inc
Priority to US00191886A priority Critical patent/US3824841A/en
Priority to NL7200771A priority patent/NL7200771A/xx
Priority to DE2204447A priority patent/DE2204447C3/de
Priority to FR7203736A priority patent/FR2126724A5/fr
Priority to ES399483A priority patent/ES399483A1/es
Priority to JP1232072A priority patent/JPS5434277B1/ja
Priority to CA133,972A priority patent/CA959806A/en
Priority to SE7201304A priority patent/SE375920B/xx
Priority to IT48144/72A priority patent/IT949709B/it
Priority to IL38697A priority patent/IL38697A/xx
Priority to BE778981A priority patent/BE778981A/nl
Priority to CH168272A priority patent/CH553980A/fr
Priority to GB531572A priority patent/GB1376664A/en
Priority to DK53672*#A priority patent/DK132989C/da
Priority to FR7233719A priority patent/FR2156607A2/fr
Priority to US00292540A priority patent/US3848796A/en
Application granted granted Critical
Publication of US3824841A publication Critical patent/US3824841A/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
    • G01N15/04—Investigating sedimentation of particle suspensions
    • G01N15/05—Investigating sedimentation of particle suspensions in blood
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B04—CENTRIFUGAL APPARATUS OR MACHINES FOR CARRYING-OUT PHYSICAL OR CHEMICAL PROCESSES
    • B04B—CENTRIFUGES
    • B04B5/00—Other centrifuges
    • B04B5/02—Centrifuges consisting of a plurality of separate bowls rotating round an axis situated between the bowls
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B04—CENTRIFUGAL APPARATUS OR MACHINES FOR CARRYING-OUT PHYSICAL OR CHEMICAL PROCESSES
    • B04B—CENTRIFUGES
    • B04B5/00—Other centrifuges
    • B04B5/04—Radial chamber apparatus for separating predominantly liquid mixtures, e.g. butyrometers
    • B04B5/0407—Radial chamber apparatus for separating predominantly liquid mixtures, e.g. butyrometers for liquids contained in receptacles
    • B04B5/0414—Radial chamber apparatus for separating predominantly liquid mixtures, e.g. butyrometers for liquids contained in receptacles comprising test tubes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
    • G01N15/04—Investigating sedimentation of particle suspensions
    • G01N15/042—Investigating sedimentation of particle suspensions by centrifuging and investigating centrifugates

Definitions

  • This invention relates generally to diagnostic exami-' nation of whole blood and more particularly concerns the provision of improved and means for whole blood sedimentation study.
  • Present methodology involves essentially the mixing of a whole blood sample with a selected anticoagulant, introducing this well mixed sample in a vertically arranged glass tube and permitting the red cells of the sample to sediment under the influence of gravity. This process is slow, usually taking sixty or more minutes.
  • the only accepted variations in this method takes the form, singly or in combination, merely of changing the length of the glass tubes employed, varying the bore of such tubes, careful selection of the anticoagulant employed and/or modification of the degree of dilution utilized. None of these variations have alleviated the principal drawback to adoption of the sedimentation test as a routine procedure, this drawback being that present sedimentation rate tests methods are too time consuming for routine employment or mass studies.
  • Another object of this invention is to provide an improved sedimentation study method which provides comparative information on the sedimentation behavior of whole blood from normal persons and from persons suffering from functional disorders, this information being provided quickly and with reliability, the method being free from the sensitivity of prior methods to dispostion of the test samples during performance thereof; and also which results can be obtained approximately equivalent to standard methods of sedimentation testing and also can provide a sedimentation study result independent of hematocrit effect of the sample.
  • a sedimentation study method for whole blood com prising the steps of applying greater than gravity force less than 8.25 G laterally to a substantially vertically oriented column of whole blood sample in a repeated series of applications and rotating the column about its own vertical axis between each application of force; thereafter determining the concentration of cells in the resulting packed portion of said sample.
  • a comparison is made between the start level and the treated level.
  • the column may be then fully packed by centrifugation at 100 G or the like and a comparison again made to the treated column level. A ratio then is determined of the two results to provide a hematocrit independent value.
  • FIG. 1 is a diagrammatic representation illustrating an improved sedimentation rate study method according to the invention
  • FIG. 2 is a perspective view of the sedimentation rate centrifuge constructed in accordance with the invention.
  • FIG. 3 is a vertical section taken through the centrifuge of FIG. 2 along the lines 3-3 and in the direction indicated;
  • FIG. 4 is a vertical section taken through line 44 of FIG. 2 and in the direction indicated;
  • FIG. 5 is a top plan view of the centrifuge arrangement as shown in FIG. 2;
  • FIG. 6 is a vertical section taken through a modified embodiment of theinvention. I
  • FIG. 7 is a perspective view of a further modified embodiment of the invention.
  • the method of studying the sedimentation characteristics of whole blood in accordance with the invention capitalizes in part upon the fact that the blood from a normal, healthy individual has greater suspension stability than does blood from a sick individual.
  • Three phases are known to occur during the sedimentation of wholeblood. The first is characterized as the phase of rouleaux formation. During this phase, the red cells of the whole blood stack together in what is defined in the art as rouleaux. This phase occupies the first few minutes subsequent to filling of the sedimentation tube with sample. Next begins the phase of maximum sedimentation wherein after about three to five minutes, the red cell rouleaux reach their maximum velocity of fall.
  • This velocity is dictated by theaverage density of the rouleaux and the viscosity of the plasma through which they are falling.
  • the last phase concerned is characterized as the, packing phase. As the rouleaux reach the bottom of the sedimentation tube, they pack and, as a consequence, the average rate of fall decreases and eventually, when packing is complete, no further change, occurs.
  • the ascending plasma is forced to traverse the descending red cells.
  • a slight inclination of the column up to about 6 from vertical is permissible with the method of the invention, particularly to avoid spilling of the sample during the run.
  • greater than gravitational force is applied laterally to a long thin column of whole blood sample by rotation thereof in a centrifuge capable of delivering a force in the range of 2 to 12 G with the test taking from one-half hour at a minimum G to about one minute at the high end of the aforesaid range.
  • the higher the G Force the shorter the elapsed time of the test.
  • the net effect is to force the red cells to traverse the plasma component of the blood over a very short distance since the effective cross-sectional area of the tube is now vast relative to the wall surface area and the red cells cannot collect in one portion of the tube against the wall so as to permit the plasma to escape freely elsewhere.
  • the laterally applied force acts to pack the red cells rapidly, permitting the plasma physically to change location therewith and approach the final packing state over a much shorter time period, than normally would be expected under gravitational force.
  • One example utilizing the method according to the invention permits the completion of the packing stage under gravity subsequent to the periodic application of the greater than gravity force and the level of the packed red cell rouleaux observed and compared with that of a normal blood standard sample treated under the same conditions.
  • Another example of the subject method involves the obtaining of a packing factor after the said periodic cycles and a second packing factor on.maximum packing by centrifugation under more than G.
  • the ratio of these factors is a value indicative of the presence of asymmetric protein, a fact important to state of health evaluations and independent of hematocrit.
  • the selection'of the duration of the centrifugation cycles as well as their number are dependent also upon the speed of the drive or synchronous spinner motor utilized, the diameter of the column and of the sedimentation tube utilized, and the degree of cant or tilt permitted.
  • Another method of practicing the invention involves a program selected to use four cycles of applied force laterally to the column and of45 second duration each. Between the first and second, the second and third and the third and fourth cycle of centrifugation, the columns are rotated about their own vertical axes. Care is taken to assure that the axial rotation of the columns take place only when the force applied laterally to the long axes of the columns is less than one G. This condition occurs when the column isat rest, substantially at rest or, to put it another way, begins its translation in its circumferential rotation with and on the centrifuge head, that is, to the spool on which the columns ride,
  • test sample column is rotated about its own long axis, preferably 180.
  • the rotation of the tube containing the'test sample column on its axis must be sufficiently gradual so as not to sever the adhesion between the column of cells and the tube wall. Sharp rotation will leave the cells, while the wall moves. Since the purpose generally of the aforesaid column rotation is to effectively force the cells through the plasma component of the sample so as to provide a reasonably reproducible packing factor, movement of the cells with tube wall during said tube rotation on its axis is mandatory.
  • the sedimentation test method will provide test results equivalent to the Wintrobe standard method of sed.rate testing.
  • the blood sample S is taken from the patient by means of a syringe 12.01" the like, transferred to avessel and mixed with any one of a plurality of selected anticoagulants.
  • a predetermined amount of mixed sample is placed in a long, thin tube, sometimes referred to in the art as a microhematocrit tube 16 and which constitutes the test sample.
  • the tube 16 is filled to a standardized depth.
  • the steps involved in the production of this'test sample are well known in the art and is represented by box 14 in FIG. 1.
  • the microhematocrit tube 16 generally of 2 'mm diameter is placed substantially vertically in one of the tube holders 46 of the centrifuge 20.
  • the other holders are likewise employed .with other samples so that the centrifuge is balanced.
  • other configurations of tube holders are contemplated.
  • the range of speed of rotation of the centrifuge 20 preferably is selected between 200 and 1,000 revolutions per minute so that an effective centrifugal force of approximately 7.25 is provided.
  • the motor 22 of the centrifuge 20 is energized and the centrifuge is caused to operate, here in a clockwise direction, for a relatively short spin, say about 20 seconds.
  • the centrifuge then is stopped and brought to rest.
  • the tube holder 18 and its tube 16 arecaused to rotate about its own long axis and the centrifuge 20 again is caused to rotate, applying a force of approximately 6.25 to 8 G to the vertically oriented column of test sample in tube 16.
  • This second rotation also is for a short duration, again about 20 seconds, after which the centrifuge 20 is brought to a rest condition and the tube holder 18 and the tube 16 therein again are rotated 180 about its own axis.
  • a reversing motor is used so that the centrifuges direction of rotation is changed with each cycle.
  • the rotation of the test column about its own axis may be in a direction opposite to the immediately preceding direction of rotation of the centrifuge 20 because it is easier to effect rotation of the tube and tube holder about their own long axes due to the inertia of the centrifuge head in starting.
  • a unidirectional centrifuge also can be used with the direction of rotation of the tubes and tube holders about their own axes remaining unchanged from cycle to cycle.
  • the first two short spins are for the purpose of accelerating rouleaux formation by shunting the red cells back and forth through the plasma to cause them to collide without really effecting the sedimentation thereof.
  • the red cells are either isolated or at most in groups of two to four cells and as a result they are not moved any appreciable distance by the approximately 6.25 to 8 G force applied perpendicular to the long axis of the tubes during the first two short spins.
  • the cells are moved further than they would move under gravity influence during this period and collisions between individual cells for the formation of rouleaux accelerated.
  • the rouleaux formation in blood from an ill person has taken place to a larger extent than it would if the blood sample originated from a normal or healthy person.
  • the rouleaux formation is such that the approximately 6.25 to 8 G force may be applied when the test sample is experiencing the second phase of sedimentation, that is the maximum velocity of descent of the formed rouleaux in the test sample from the ill person, a time whereat the sedimentation rate can be most effectively accelerated and compared to the reaction of the standard or normal test sample wherein rouleaux formation is barely initiated.
  • the centrifuge 20 is caused to rotate again to apply a force of approximately 6.25 to 8 G perpendicular to the long or vertical axis of the upstanding sample column, but this time, the application of said G force laterally to the columnis continued for a period of about 60 seconds, a long enough period of time to move the red cell rouleaux physically to one side of the tube.
  • the tubes and tube holders once again are brought to rest condition, and the said tubes and tube holders again are rotated 180 about their own axes. Two more 20 second spins follow with intermediate rotation of the tubes and tube holders about their own vertical axes. These final two spins are intended to aid the red cell column to re-establish itself in its vertical tube so that its level can be read.
  • the rouleaux layer is permitted to fall free of plasma hindrance.
  • the plasma component is permitted to escape from the red cell rouleaux column held against the tube wall. No hindrance to such passage can be expected since the cell column is held against the wall of the tube by the approximately 6.25 to 8 G force while the l G natural gravitational force applied axially causes them to travel to the bottom of the tube.
  • the tubes having been filled to a standard depth, the level of the packed cells is read by comparison to a fixed scale either mounted on the centrifuge-head as shown in FIGS.
  • the range of G force applied in the course of operating the particular embodiment is approximately 6.25 to 8 G's with a generally preferred force application of 7.25 G.
  • the cycles set forth as an example in FIG. 1 give results in terms of a sedimentation rate correlative with and equivalent to the value obtained by following the well known Wintrobe method of sedimentation rate determination.
  • a result approximately equivalent to other standard method values can be obtained by variation of the number and duration of the cycles.
  • the cycles are of substantially of equal duration; in one example, 45 seconds under the 6.25 8 G applied in four cycles with rotation of the tubes and columns about their own vertical axes between each cycle.
  • a ratio of initial to packing level is taken.
  • the tubes may then be packed to a maximum extent by application of G force of at least G and a ratio of the first and maximum packing levels taken.
  • the ratio of the resultant maximum packing factor and the first packing factor is taken with the resultant value, here termed a ZSR, a value independent of hematocrit fluctuations.
  • the red cell sedimentation has been accelerated by increasing the greater than gravity force applied at the time when abnormal blood would be most sensitive to the multi G effect than blood from a normal healthy person, this time being during the maximum velocity phase of sedimentation reached prior to the time it would be reached if the sample were from a normal healthy person.
  • the multi G force is applied laterally to a thin vertically oriented column of blood sample to obviate the problems of channelizing occurring where sedimentation does not act absolutely parallel with the walls of the vessel containing the sample column; the container effectively being transformed from the long thin vertically arranged tube to one which has a wide diameter.
  • the intermittent rotation of the column about its own vertical axis between the centrifugal spins is intended to hold the red cells on one side of the column while permitting the plasma to move on the other side so that, in effect, the red cells are repeatedly forced to move through the plasma with a reproduced packing factor being the ultimate result.
  • the performance of the method above described required a centrifuge capable of applying the preferably G force in the range of 6.25 to 8 G in separate cycles of predetermined duration.
  • the centrifuge is required to rotate the tube containing the sample in a circumferential path about the axis of rotation with the tube being in substantially vertically oriented disposition parallel to the axis of rotation of the centrifuge head although a cant from vertical of up to 6 is permitted, contrary to standard sedimentation rate methods.
  • the centrifuge is required not only to permit rotation of the tube along said circumferential path for a predetermined length of time and then the tube periodically must be brought at least to a momentary substantially rest or stationary condition, then rotated page, the contents of the sample tube having a tendency to remain stationary while the tube and tube holder rotate. This must be avoided.
  • the column contents of the sample tube must rotate axially with the tube wall and care must be taken to assure only such rotation.
  • the centrifuge constructed in accordance with the invention and illustrated in FIGS. 1 to 5 comprises a motor 22, generally one which is reversible, for rotating a head 24 in the range of 200 to 1,000 R.P.M. Generally, the speed of rotation can be varied easily by selection of heads of different diameter. The effective force output preferred is in the range of 6.25 to 8 'G.
  • the shaft of the motor 22 is coupled to the head 24 by fastening means 28.
  • the head 24 comprises a spool mounted for rotation on a shaft32;
  • the shaft 32 has an enlarged end 34 having a passage'36 to receive the shaft 26 of the motor 22.
  • a spur wheel 38 having circumferential teeth 40 is mounted at the opposite end of shaft 32 coaxial with the spool 30.
  • a locking ring 41 is fastened to the shaft about its own axis a predetermined number of degrees,
  • the centrifuge also should have timing means T for selectively controlling and/or varying the duration of the cycles.
  • the duration of the successive cycles are not equal but follow a definite program.
  • Another example of the subject method has successive equal duration cycles. The greater the G force, the shorter the cycles and total elapsed time.
  • the centrifuge In addition to the means required to rotate the individual test sample holders between cycles when the centrifuge is brought to a substantially rest condition, the centrifuge must be provided with means whereby the tube holder is brought to rest or at least substantially to rest in its travel along its circumferential path before the rotation of the tube holder about its vertical axis can take place.
  • the spool 30 carries a plurality of openings 44 circumferentially disposed to receive tube holders 46.
  • the tube holders 46 are arranged in diametrically opposed pairs for balance, only one pair being shown in the FIGS. l-6 for convenience.
  • Each of the tube holders 46 is provided with a pinion wheel 48 either secured frictionally or otherwise thereto or integral therewith.
  • the body of holder 46 may be transparent so that the tube 16 may be viewed and a graduated scale 52 mounted on the spool 30 adjacent the tube holder for reference in reading.
  • the openings 44 are so arranged that the pinion wheels 48 mesh with the circumferential teeth 40 of the spur wheel 38.
  • Each tube holder 46 is constructed with a top opening bore 50 capable of receiving in vertical orientation, the microhematocrit tube 16 which contains the sample of blood to be tested.
  • Each tube holder 46 may have a leaf spring 51 within the bore as an aid in maintaining the proper disposition of the tube.
  • An upstanding pin 54 is secured to the upper disc 56 of the spool and a slot 58 is provided in the spur wheel 38. Slot 58 is configured in the form of a segment of an are, as shown in FIG. 5.
  • the length of the slot is selected to assure that the rotation of the pinion wheel 48 is taken through exactly
  • the spool 30 is mounted to the shaft 32 so that it is freely rotatable, the spur wheel 38 being secured so that it rotates with shaft 32. After the pin 54 reaches the end of slot 58, no further rotation of the pinion wheel 48 can take place.
  • the motor 22 is brought to rest and then started in the reverse direction. At this time, the pinion wheel 48 must first rotate, owing to the inertia of the spool 30, until the pin 54 reaches the other end of the slot 58.
  • the carrier tube and hence the microhematocrit tube 16 is caused to rotate exactly 180 with each reversal of the driving motor 22.
  • Deceleration of the motor 22 before it stops has the same effect on the spool 30 as the reversal of the motor, so that the 180 rotation of the tube 16 takes place before the tube 16 comes to rest.
  • the tubes must be at rest before rotation about their own axes to avoid rotation only of the tubes rather than the column. This problem can be overcome by introducing a constant drag on the spool 30 such as, for example, a magnetic induction brake or a friction pad (not shown).
  • a preferred method of alleviating the said deceleration effect is the provision of an interlocking device designated generally by reference character 60 (FIG. 4).
  • the interlocking device 60 comprises a metal strip 61 pivotally secured to a block 62 which, in turn, is attached to the inside wall of disc 56 of the spool30.
  • the strip 61 is pivoted as at 64 to move in radial slot 66.
  • a weight or mass 68 is provided at the lower end of strip 61 and secured thereto. When the spool 30 is rotating, the mass 68 is held radially outward of the spool 30 so that the strip 61 engages the spur wheel 38. This condition remains until the motor speed falls to zero.
  • FIG. 6 there is illustrated a sedimentation rate centrifuge which has been modified so as to obviate the need for a reversing motor, utilizing instead a magnetic solenoid electrically interlocked so that the 180 rotation of the tubes can be brought about entirely by the same.
  • the centrifuge 20 incorporates a motor 22 and a head 24'.
  • the motor 22' drives the shaft 32 by means of reduction gears 72 and 74.
  • the shaft 32 carries a pair of spaced discs 76 and 76 which are secured thereto for rotation therewith.
  • a helical splined portion 78 is likewise fixed to the shaft 17 to rotate therewith.
  • a spur wheel 80 engages with the splined portion 78 of the shaft 17 so that longitudinal movement of the spur wheel 80 with respect to the splined portion 78, causes the spur wheel 80 to rotate with respect to the shaft 17 by an amount sufficient to rotate pinion wheels 48 through 180.
  • the pinion wheels 48 each carries a chuck or holder 46 into which the lower end of a microhematocrit tube 16 can be inserted.
  • Aligned openings82 are provided in disc 76 so as to support the microhematocrit tube 16 in vertical orientation, parallel to the rotational axis'of shaft 17.
  • the lower face of spur wheel 80 carries a thrust race 84.which can be urged upwards by means of the lever 86 mounted for vertical pivotable movement about shaft 88.
  • the thrust race 84 comprises a receptor ring 90 secured to the lower face of spur wheel 80 and a lower ring 92 having protrusions 94 arranged for engagement with shallow recesses 96 formed in ring 90.
  • the end 98 of lever 86, remote from the race 84, is operated by means of solenoid 101. When the solenoid 101 is not energized, the spur wheel 80 is urged downward by light, annular spring 102, arranged disposed between disc 76 and the spur wheel 80.
  • the assembly consisting of the shaft 32' with its splined portion 78, the discs 76 and 76 and the pinions 48 rotate together in suitable bearings (not shown) while the motor 22, the solenoid 101 and the lever 86 remain stationary.
  • FIG. 7 A further modified embodiment of the centrifuge apparatus according to the invention is illustrated in FIG. 7 and designated by reference character 100.
  • Apparatus as described herein particularly is adapted to practice the method of the invention where the cycle utilized comprises four cycles of 45 second duration applications of greater thangravity force laterally to substantially vertically arranged columns of whole blood with means provided to effect limited rotation of each column about its own axis between each force application by reversal of the direction of rotation of the centrifuge head after each cycle.
  • the centrifuge apparatus 100 includes a-housing 102, including a troughlike portion 104 and a cover 106.
  • Wall 108 of housing 102 carries exterior accessible switch levers 110 and 112 for activating the power and buzzer means respectively which will be described hereinafter.
  • Indicator lights 114 and 116 likewise are provided.
  • Start switch 118 for initiating each test operation is provided.
  • the electrical control components of apparatus 100 are mounted within the troughlike portion while the head, centrifuge 120, drive means 122, and the timing means 124 are mounted on the cover portion, the centrifuge head being removably mounted to the protruding portion of the motor drive shaft 154 of means 122.
  • the drive means -122 and timer means 124 are mounted to be enclosed within the housing 102 when the cover 106 is engaged'onto the portion 104.
  • the centrifuge head comprises a spool formed by mounting a spinner plate 126 fixedly secured to the shaft 128 for rotation therewith, and mounting a disc 130 to the upper end of said shaft 128 with the disc 130 arranged coaxial with said spinner plate 126 and. being rotatable therewith.
  • the shaft 128 is secured to the motor drive shaft 154 as by suitable means such as set screw 127.
  • Gear support means 132 is arranged secured to the cover 106 and includes a collar portion 192 having a flat upper surface 192, and a circumferential flange portion which is fastened to the cover 106.
  • the spur gear 134 has a circumferential ring portion 134 carrying circumferential teeth 134" and a central disc portion 135 to which it is fixedly mounted and by which the spur gear is mounted for independent rotation about the shaft 128, that is, independent of rotation of the spinner plate 126.
  • a coating or film of thin machine oil or vacuum pump oil is applied to the surface 192 of collar portion 192 to provide a friction drag upon the disc portion 135 which rests thereupon, and which, of course is transferred to the ring gear 134 and thereby is applied directly to the spinner plate 126.
  • Tube holders 136 are mounted on spinner plate 126 for movement therewith about the axis of shaft 128.
  • the holders are spaced circumferentially substantially equidistant one relative to the other closely adjacent the peripheral edge of the spinner plate 126.
  • Each tube holder 136 has a top opening cavity 137 defined therein to receive the lower end of sample 'tube and has resilient means for gripping said tube seated therein, such as O-ring 139.
  • Each holder is mounted on the upper end of a shaft 138 which extends through suitable openings formed in said plate 126.
  • Pinion gears 140 fixedly are secured to the opposite ends of each shaft 138 thereby mounting the holders 136 on plate 126.
  • the holders 136 are rotatable with rotation of gears 140.
  • a spur gear in the form of ring gear 134 is arranged so that its teeth 134" are meshed with plural pinion gears 140.
  • rotation of the plate 126 will effect rotation of gears 140 while the ring gear 134 remains stationary, rotating holders 136 about their own vertical axes independent of the rotation of the shaft 128.
  • Limit means in the form of the upstanding pin 142 secured to the support means 132 and movable within the limit slot 144 formed in the spinner plate 126 is-provided to limit the independence of movement of the spinner plate 126 and gear 134, thereby limiting the degree of rotation of the gears 140 about their own axes.
  • the limit means described may be said to comprise a lost motion coupling between the plate 126 and gear 134.
  • the disc 130 has a plurality of bottom opening recesses 146 formed equispaced about the peripheral edge thereof and arranged in alignment with the axes of the holders 136 but slightly offset inwardly therefrom so that one end of the sample tube 150 can be seated within cavity 137 of holder 136 and the upper end retained within the respectively matching recess 146 to position the tube substantially vertically arranged but canted inwardly at its upper end toward the shaft 128.
  • tubes 150 are disposed,
  • Motor mount 152 is secured to the undersurface of cover 106 with the drive shaft 154 thereof protruding through a suitable opening formed in said cover 106.
  • the drive means 122 for the apparatus 100 is supplied by a 400 RPM, 60 HZ, 115 volt AC reversible direction motor 156.
  • motor 156 causes centrifugal force between 66 and 8 G to be applied laterally to the tubes 150 during the spin of header 120.
  • the particular size and RPM drive motor selected determines the centrifugal force exerted on the tubes 150, and thereby is an important factor in selection of the duration of greater than gravity application cycle and program.
  • the method of the invention requires application of the greater than gravity force laterally and periodically to the sample in the tube i.e., the sample tube 150 and the column of blood therein.
  • the duration of each cycle generally can be selected to provide results correlative with specifically known blood sedimentation methods.
  • timer means 124 is provided to effect rotation of the spinner plate automatically through a sequence of four cycles of 45 seconds duration with the reversal of direction and rotation of the columns 180 about their own axes between each application of centrifugal force.
  • the timer motor 156 is an AC 60 cycle, 1 volt motor delivering RPH.
  • the timing means 124 operates switch means, 184,186 which operates relays 184" and 186" automatically taking the sample columns through the selected test program.
  • a timing means 124 comprises a timer motor 158 mounted on platform 159, which in turn is secured suspended below the cover 106 by means of bolts 160 and spacers 162.
  • the resultant drive shaft 164 of motor 158 is passed through a suitable opening in the platform 159 and wheel gear 166 is mounted at the free end thereof for rotation therewith.
  • a second wheel gear 168 is coupled to gear 166 and is driven thereby.
  • Gear 168 is fixedly secured to shaft 170 for rotation therewith.
  • One end of shaft 170 is seated in journal 172 and the other end carries timer disc 176.
  • Timer disc 176 is secured to shaft 170 and continuously rotates therewith so long as timer motor 156 operates through the complete test program.
  • the timer disc 176 has three paddle assemblies 178, 178' and 178" mounted thereto about the periphery thereof with the paddles 180, 180' and 180" extending outwardly from the circumferential edge thereof in vertical planes normal to the axis of shaft 170. As illustrated, disc 176 is rotatable in the direction of arrow 177 with the paddle assemblies 178, 178' and 178" fixed in an equispaced series along said path. An upstanding pin 182 is secured normal to the disc 176 and rotates therewith.
  • the paddle assemblies 178, 178 and 178" when considering the direction of rotation of the disc, can be said to be substantially equispaced one relative to the others with paddle assem' blies 180 and 180" being disposed 180 apart.
  • a pair of push-button activated switches 184 and 186 are arranged with their actuators 184' and 186' mounted to suitable bracket means (not shown) secured to theplatform 159 so that the actuator 184' of switch 184 is arranged in the path of travel of the paddles 180, 180' and 180" of paddle assemblies 178, 178' and 178" whereby each respective paddle can engage and depress said actuator 184' by engaging same during passage therepast during rotation of the disc 176.
  • the actuator 186' of switch 186 is positioned to intercept the pin 182 whereby the continuing rotation of disc 176 causes pin 182 first to bear against actuator 186' to depress same. On passing of said pin 182 past actuator 186', said actuator returns to its normal condition.
  • the switch 184 is connected to relay assembly 184" which is electrically coupled to the reversible synchronous drive motor 156 to cause reversing of the direction of said motor each time the actuator 184' is depressed.
  • the switch 186 is connected to relay assembly 186" operatively coupled electrically to both the drive motor 156 and to the buzzer means 190. Depression of the actuator 186 energizes the buzzer 190 and release of the actuator 186' from engagement with the pin 182, causes de-energization of the drive or spinner motor 156.
  • a friction or other drag is applied to the centrifuge head so that application of braking force to'the motor 156 on de-energization of the same, causes a braking force to be applied directly to the head. Accordingly, the tubes and the columns of test samples therein will be prevented from being rotated about their own vertical axes at least until the centrifuge head 120 starts up after coming to a substantially full stop, however momentary.
  • the friction drag described may be applied by means of the engagement of the collar portion 192 of gear support means 132 with the facing surface of gear 134 and the provision of a coating or film of light machine v head 120 is spun.
  • collar portion 192 being an upstanding ring integral with the support means 132, it may take the form of a foam collar (not shown) secured thereto or even arranged coaxial about the shaft 128. This oil interface friction drag arrangement is illustrated in detail in FIG. 12.
  • Samples of whole blood are taken and placed respectively in closed end, elongate tubes known as sedimentation tubes.
  • the tubes are filled with sample to a predetermined level mark.
  • the tubes containing the test samples are placed between the disc 130 and the spinner plate 126, the lower ends of the tubes seated within the tube holders 136 while the upper ends are seated in the recesses 146 and held firmly by the resilient means 139.
  • the switch levers 110 and 112 are actuated respectively activating the apparatus 100.
  • the start toggle switch 118 is actuated initiating thetest procedure and causing the spinner motor 156 to operate in one direction, say clockwise.
  • the centrifuge head 120 comes to a momentary halt with the pin 142 at one end of the opening or slot 144. The centrifuge head 120 then begins to rotate in the clockwise direction.
  • the gear 134
  • the pinion gears 140 being mounted on the spinner plate 126, and meshed with the gear 134, will move along the circumference of now stationary gear 134 and will rotate about their respective axes until engagement of the pin 142 at the opposite ehd of the eccentric slot 144 will drive the gear 134 with the rotation of the spinner plate 126, limiting the rotation of the pinion gears 140 to 180.
  • the rotation of the pinion gears 140 rotates the tube holders 136 and with same, the tubes 150 and the column of blood sample will be rotated.
  • the braking must be gradual and not abrupt so that separation of the column from the inner tube wall will not occur. This is accomplished by the friction drag applied to plate 126.
  • the column must rotate with the tube wall.
  • the spinner motor 156 operates to drive the centrifuge head 120 in a clockwise direction for the next cycle of 45 seconds. At the elapse of 45 seconds, thenext paddle 180 will have brought around to depress the actuator 184 and cause a second reversal of the spinner motor 156. The spinner plate 126 again is brought to a momentary halt, and, in reversing direction,,first moves relative to the gear 134 to bring the pin now at the other end of the slot 144, back to the first,
  • Coupled rotation of the spinner plate 126 and gear 134 is resumed for another and final 45' second interval.
  • the timer plate 176 is continuously rotating during these last described operations, and, accordingly, continues to rotate.
  • the pin 182 is brought into contact with the actuator 186' by the continued rotation of the timer disc 176, the actuator 186 is released from its depressed condition.
  • the motor 156 is de-energized and the centrifuge head is brought to a halt.
  • the tubes 150 with their now partially packed red cell layer are each compared with the initial level and a ratio taken which is reflective of the sedimentation rate of the sample. It is possible then to subject the tubes and the samples therein to substantially greater G force, such as 100 G in a conventional centrifuge so as to fully pack the red cells. The ratio of the fully packed cell level to the partially packed level is taken. This ratio, the resultant sedimentation rate taken to provide what can be described as a Zeta Sedimentation Ratio, is independent of the effect of hematocrit and is related to the state of health of the source individual.
  • Zeta refers to the Zeta potential between cells.
  • the Zeta potential to which reference is made is effected by the concentration of asymmetrical protein molecules in the blood such as fibrinogen, gamma globuin, etc.
  • the Zeta Sedimentation Ratio in a fashion analogous to the sedimentation rate has been found to be indicative of the state of health of the source individual.
  • the value described here as the-Zeta Sedimentation Ratio or ZSR provides a determination of the packing factor or closeness of packing of the cells.
  • the ZSR is independent of the effect of hematocrit," the relative quantity of redcells in the whole blood sample.
  • test column is translated along a circular path at a rate sufficient to apply a centrifugal force greater than one G laterally to the test column in periodic serial intervals of predetermined duration and the test column is rotated about its own axis between-said intervals only when said centrifugal force acting laterally is less than one G.
  • plications of a first duration to accelerate the formation of rouleaux in the sample column next in a third application having a duration approximately three times longer than each of the first two applications whereby to cause the formed rouleaux and the plasma components to migrate one through the other with the formed rouleaux assuming a thin layer on one side of the column, applying at least one application of greater than gravity force for the same duration as each of said first two applications, the column being brought to restso that the rouleaux layer is permitted to fall to the bottom of the column for observation of level.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Hematology (AREA)
  • Centrifugal Separators (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
US00191886A 1971-02-08 1971-10-22 Method for sedimentation study Expired - Lifetime US3824841A (en)

Priority Applications (16)

Application Number Priority Date Filing Date Title
US00191886A US3824841A (en) 1971-02-08 1971-10-22 Method for sedimentation study
NL7200771A NL7200771A (nl) 1971-02-08 1972-01-20
DE2204447A DE2204447C3 (de) 1971-02-08 1972-01-31 Verfahren und Zentrifuge zum Zentrifugieren von Blut für die Ermittlung charakteristischer Blutsenkungswerte
GB531572A GB1376664A (en) 1971-02-08 1972-02-04 Blood fractionizing method and means
JP1232072A JPS5434277B1 (nl) 1971-02-08 1972-02-04
CA133,972A CA959806A (en) 1971-02-08 1972-02-04 Blood fractionizing method and means
SE7201304A SE375920B (nl) 1971-02-08 1972-02-04
IT48144/72A IT949709B (it) 1971-02-08 1972-02-04 Metodo e mezzi per il fraziona mento del sangue
FR7203736A FR2126724A5 (nl) 1971-02-08 1972-02-04
BE778981A BE778981A (nl) 1971-02-08 1972-02-04 Werkwijze voor het fractionneren van bloed en middelen voor hetuitvoeren van deze werkwijze
CH168272A CH553980A (fr) 1971-02-08 1972-02-04 Procede pour separer du sang entier en fractions et appareil pour la mise en oeuvre de ce procede.
ES399483A ES399483A1 (es) 1971-02-08 1972-02-04 Un metodo y su correspondiente centrifugadora para separar de manera reproducible la sangre completa en fracciones.
IL38697A IL38697A (en) 1971-02-08 1972-02-04 A method of obtaining a sedimentation index value of whole blood and centrifuge therefor
DK53672*#A DK132989C (da) 1971-02-08 1972-02-07 Fremgangsmade til adskillelse af blod i fraktioner og centrifuge til udovelse af fremgangsmaden
FR7233719A FR2156607A2 (en) 1971-02-08 1972-09-22 Blood sample centrifuge
US00292540A US3848796A (en) 1971-02-08 1972-09-27 A centrifuge apparatus for sedimentation study

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11316671A 1971-02-08 1971-02-08
US00191886A US3824841A (en) 1971-02-08 1971-10-22 Method for sedimentation study

Publications (1)

Publication Number Publication Date
US3824841A true US3824841A (en) 1974-07-23

Family

ID=26810757

Family Applications (1)

Application Number Title Priority Date Filing Date
US00191886A Expired - Lifetime US3824841A (en) 1971-02-08 1971-10-22 Method for sedimentation study

Country Status (14)

Country Link
US (1) US3824841A (nl)
JP (1) JPS5434277B1 (nl)
BE (1) BE778981A (nl)
CA (1) CA959806A (nl)
CH (1) CH553980A (nl)
DE (1) DE2204447C3 (nl)
DK (1) DK132989C (nl)
ES (1) ES399483A1 (nl)
FR (1) FR2126724A5 (nl)
GB (1) GB1376664A (nl)
IL (1) IL38697A (nl)
IT (1) IT949709B (nl)
NL (1) NL7200771A (nl)
SE (1) SE375920B (nl)

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4028930A (en) * 1976-04-08 1977-06-14 Enrique Moreno Multiple holder for determining hematocrit
FR2435714A1 (fr) * 1978-09-06 1980-04-04 Clinicon Int Gmbh Procede pour effectuer une mesure rapide de la sedimentation du sang et centrifugeur pour la mise en oeuvre de ce procede
US5187975A (en) * 1989-12-26 1993-02-23 Meiji Milk Products Co., Ltd. Apparatus for examining and determining the viscosity of a liquid in a container
US5269174A (en) * 1989-12-26 1993-12-14 Meiji Milk Products Co., Ltd. Method and apparatus for examining and determining the viscosity of a liquid in a container
WO1996001990A1 (en) * 1994-07-12 1996-01-25 Bull Brian S Rapid determination of blood sedimentation rate
WO1996039618A1 (en) * 1995-06-06 1996-12-12 Brigham And Women's Hospital Determining erythrocyte sedimentation rate and hematocrit
US6204066B1 (en) * 1999-06-25 2001-03-20 Robert A. Levine Rapid method for determining the erythrocyte sedimentation rate in a sample of anticoagulated whole blood
US20020042141A1 (en) * 1996-05-16 2002-04-11 Diesse Diagnostica Senese S.R.L. Apparatus for the preparation and the performance of sedimentation velocity tests on organic liquids and other substances
US20020129553A1 (en) * 1999-06-04 2002-09-19 Pipidol Pty Limited Louvre system
US20060068492A1 (en) * 2002-11-19 2006-03-30 Kuiwon Choi Hybrid bioreactor for cell culture
CN108325759A (zh) * 2018-03-21 2018-07-27 徐永香 一种分体安装式分流离心装置
WO2018093740A3 (en) * 2016-11-18 2019-06-13 North Carolina State University Multi-sample chamber for extended term microscope imaging

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3998383A (en) * 1975-07-16 1976-12-21 E. I. Du Pont De Nemours And Company Gradient separation apparatus
DE2556915C3 (de) * 1975-12-17 1979-08-23 Compur-Electronic Gmbh, 8000 Muenchen Zentrifuge für medizinische Untersuchungen

Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2514260A (en) * 1946-09-19 1950-07-04 Haemic Res Lab Inc Clinical testing device for blood
US2741913A (en) * 1954-07-20 1956-04-17 Dovas Nicholas Blood sedimentation rack
US3009388A (en) * 1957-12-30 1961-11-21 American Optical Corp Apparatus for determining fluid fractions and sedimentataion rates
US3026717A (en) * 1958-03-05 1962-03-27 Danielsson Apparatus for the determination of the sedimentation rate of blood
US3373601A (en) * 1964-08-05 1968-03-19 Monn Stanislaus Device for the analysis of the sinking speed of blood corpuscles in a calibrated tube
US3460752A (en) * 1965-11-09 1969-08-12 American Hospital Supply Corp Apparatus for performing plasmapheresis in situ
US3503709A (en) * 1966-12-22 1970-03-31 Donald E Yochem Method and system for testing blood samples for thrombus formation time
US3518057A (en) * 1966-04-22 1970-06-30 Huron Road Hospital Method and apparatus for thrombus formation time determinations
US3695842A (en) * 1970-03-12 1972-10-03 Intern Technidyne Corp Method and system for analyzing a liquid

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2514260A (en) * 1946-09-19 1950-07-04 Haemic Res Lab Inc Clinical testing device for blood
US2741913A (en) * 1954-07-20 1956-04-17 Dovas Nicholas Blood sedimentation rack
US3009388A (en) * 1957-12-30 1961-11-21 American Optical Corp Apparatus for determining fluid fractions and sedimentataion rates
US3026717A (en) * 1958-03-05 1962-03-27 Danielsson Apparatus for the determination of the sedimentation rate of blood
US3373601A (en) * 1964-08-05 1968-03-19 Monn Stanislaus Device for the analysis of the sinking speed of blood corpuscles in a calibrated tube
US3460752A (en) * 1965-11-09 1969-08-12 American Hospital Supply Corp Apparatus for performing plasmapheresis in situ
US3518057A (en) * 1966-04-22 1970-06-30 Huron Road Hospital Method and apparatus for thrombus formation time determinations
US3503709A (en) * 1966-12-22 1970-03-31 Donald E Yochem Method and system for testing blood samples for thrombus formation time
US3695842A (en) * 1970-03-12 1972-10-03 Intern Technidyne Corp Method and system for analyzing a liquid

Cited By (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4028930A (en) * 1976-04-08 1977-06-14 Enrique Moreno Multiple holder for determining hematocrit
FR2435714A1 (fr) * 1978-09-06 1980-04-04 Clinicon Int Gmbh Procede pour effectuer une mesure rapide de la sedimentation du sang et centrifugeur pour la mise en oeuvre de ce procede
US5187975A (en) * 1989-12-26 1993-02-23 Meiji Milk Products Co., Ltd. Apparatus for examining and determining the viscosity of a liquid in a container
US5269174A (en) * 1989-12-26 1993-12-14 Meiji Milk Products Co., Ltd. Method and apparatus for examining and determining the viscosity of a liquid in a container
WO1996001990A1 (en) * 1994-07-12 1996-01-25 Bull Brian S Rapid determination of blood sedimentation rate
US5594164A (en) * 1994-07-12 1997-01-14 Bull; Brian S. Method and apparatus for rapid determination of blood sedimentation rate
US5731513A (en) * 1994-07-12 1998-03-24 Bull; Brian S. Method and apparatus for rapid determination of blood sedimentation rate
US5844128A (en) * 1994-07-12 1998-12-01 Bull; Brian S. Method and apparatus for rapid determination of blood sedimentation rate
US6506606B1 (en) 1995-06-06 2003-01-14 Brigham And Women's Hospital Method and apparatus for determining erythrocyte sedimentation rate and hematocrit
WO1996039618A1 (en) * 1995-06-06 1996-12-12 Brigham And Women's Hospital Determining erythrocyte sedimentation rate and hematocrit
US20030113930A1 (en) * 1995-06-06 2003-06-19 Winkelman James W. Method and apparatus for determining erythrocyte sedimentation rate and hematocrit
US20020042141A1 (en) * 1996-05-16 2002-04-11 Diesse Diagnostica Senese S.R.L. Apparatus for the preparation and the performance of sedimentation velocity tests on organic liquids and other substances
US20020129553A1 (en) * 1999-06-04 2002-09-19 Pipidol Pty Limited Louvre system
US6204066B1 (en) * 1999-06-25 2001-03-20 Robert A. Levine Rapid method for determining the erythrocyte sedimentation rate in a sample of anticoagulated whole blood
US20060068492A1 (en) * 2002-11-19 2006-03-30 Kuiwon Choi Hybrid bioreactor for cell culture
US7510866B2 (en) * 2002-11-19 2009-03-31 Korea Institute Of Science And Technology Hybrid bioreactor for cell culture
WO2018093740A3 (en) * 2016-11-18 2019-06-13 North Carolina State University Multi-sample chamber for extended term microscope imaging
US11618031B2 (en) 2016-11-18 2023-04-04 North Carolina State University Multi-sample chamber for extended term microscope imaging
CN108325759A (zh) * 2018-03-21 2018-07-27 徐永香 一种分体安装式分流离心装置
CN108325759B (zh) * 2018-03-21 2020-10-16 浙江杰迪泵业有限公司 一种分体安装式分流离心装置

Also Published As

Publication number Publication date
SE375920B (nl) 1975-05-05
DK132989C (da) 1976-08-02
DK132989B (da) 1976-03-08
JPS5434277B1 (nl) 1979-10-25
DE2204447B2 (de) 1978-11-02
IL38697A (en) 1975-05-22
NL7200771A (nl) 1972-08-10
CA959806A (en) 1974-12-24
DE2204447A1 (de) 1972-08-24
CH553980A (fr) 1974-09-13
FR2126724A5 (nl) 1972-10-06
IT949709B (it) 1973-06-11
ES399483A1 (es) 1975-06-16
DE2204447C3 (de) 1979-07-26
IL38697A0 (en) 1972-04-27
BE778981A (nl) 1972-05-30
GB1376664A (en) 1974-12-11

Similar Documents

Publication Publication Date Title
US3848796A (en) A centrifuge apparatus for sedimentation study
US3824841A (en) Method for sedimentation study
US3199775A (en) Sedimentation rate centrifuge and method determining sedimentation rate
US3768727A (en) Centrifuge with sample holding means for sedimentation study
US5731513A (en) Method and apparatus for rapid determination of blood sedimentation rate
US4814144A (en) Centrifugal analyzer rotor unit and insert elements
US4828716A (en) Apparatus and method for separating phases of blood
US4981585A (en) Centrifuge system and fluid container therefor
US5523238A (en) Method and apparatus for determining platelet function in primary hemostasis
US6153148A (en) Centrifugal hematology disposable
EP0295771A2 (en) Apparatus and method for obtaining a rapid hematocrit
JPH0690198B2 (ja) 分析用血液サンプルの調製方法およびその装置
JPH0528786B2 (nl)
JPH06507113A (ja) 遠心分離装置用の自己釣合わせ装置および方法
US4066360A (en) Device for measuring and recording spontaneous blood platelet aggregation in platelet-rich citrated plasma
US5888184A (en) Method for rapid measurement of cell layers
US4612801A (en) Coagulometer and method of measuring of the time of coagulation of samples of fluid products
US6403328B1 (en) Method of measuring erythrocyte sedimentation rate (ESR) or plasma fibrinogen of a blood sample
JPS5848053B2 (ja) コウガクブンセキヨウエキオイレルヨウキ
Ruckenstein et al. Sedimentation and adhesion of platelets onto a horizontal glass surface
US4640896A (en) Whole blood clotting timer
JP3805795B2 (ja) 既知濃度の血液成分又はプラスマ成分の溶液を作るための装置及び方法
EP1564540A2 (en) Method for determining the thickness of a cell layer
US3777172A (en) Method and apparatus for measuring the clumping of platelets in whole blood
US2908907A (en) Apparatus for counting red blood corpuscles in blood